# LOwer Maintenance Dose TICagrelor in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention

> **NCT04060914** · PHASE4 · UNKNOWN · sponsor: **Beijing Anzhen Hospital** · enrollment: 225 (estimated)

## Conditions studied

- Antiplatelet Therapy
- Coronary Artery Disease
- Percutaneous Coronary Intervention

## Interventions

- **DRUG:** Ticagrelor 90mg
- **DRUG:** Ticagrelor 90mg/60mg
- **DRUG:** Clopidogrel 75mg

## Key facts

- **NCT ID:** NCT04060914
- **Lead sponsor:** Beijing Anzhen Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-08-30
- **Primary completion:** 2020-12-30
- **Final completion:** 2021-12-30
- **Target enrollment:** 225 (ESTIMATED)
- **Last updated:** 2019-08-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04060914

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04060914, "LOwer Maintenance Dose TICagrelor in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04060914. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*